Ribozyme uses in retinal gene therapy

Progress in Retinal and Eye Research

Volumn 19, Issue 6, 2000, Pages 689-710

  Hauswirth, William W ^a,b   Lewin, Alfred S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOZYME; VIRUS VECTOR;

GENE TARGETING; GENE THERAPY; HUMAN; KINETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RETINA; RETINA DISEASE; RETROVIRUS; REVIEW; RNA STRUCTURE;

ANIMALS; GENE THERAPY; GENES, DOMINANT; GENETIC VECTORS; HUMANS; PROTEIN STRUCTURE, SECONDARY; RETINAL DISEASES; RETINITIS PIGMENTOSA; RNA, CATALYTIC;

EID: 0033862086     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(00)00007-0     Document Type: Review

References (118)

1. Altman S. RNase P in research and therapy. Biotechnology (NY). 13:1995;327-329.
2. Altschuler M., Tritz R., Hampel A. A method for generating transcripts with defined 5′ and 3′ termini by autolytic processing. Gene. 122:1992;85-90.
3. Anderson P., Monforte J., Tritz R., Nesbitt S., Hearst J., Hampel A. Mutagenesis of the hairpin ribozyme. Nucleic. Acids. Res. 22:1994;1096-1100.
4. Bartel D.P., Szostak J.W. Isolation of new ribozymes from a large pool of random sequences. Science. 261:1993;1411-1418.
5. Beelman C.A., Parker R. Degradation of mRNA in eukaryotes. Cell. 81:1995;179-183.
6. Bennett J., Duan D., Engelhardt J.F., Maguire A.M. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 38:1997;2857-2863.
7. Bennett J., Wilson J., Sun D., Forbes B., Maguire A. Adenovirus vector mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Vis. Sci. 35:1994;2535-2542.
8. Berson E. Retinitis pigmentosa. Inv. Ophth. Vis. Sci. 34:1993;1659-1676.
9. Bertrand E., Castanotto D., Zhou C., Carbonnelle C., Lee N.S., Good P., Chatterjee S., Grange T., Pictet R., Kohn D., Engelke D., Rossi J.J. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA. 3:1997;75-88.
10. Berzal-Herranz A., Joseph S., Chowrira B.M., Butcher S.E., Burke J.M. Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. EMBO J. 12:1993;2567-2574.
11. Birikh K.R., Berlin Y.A., Soreq H., Eckstein F. Probing accessible sites for ribozymes on human acetylcholinesterase RNA. RNA. 3:1997;429-437.
12. Birikh K.R., Heaton P.A., Eckstein F. The structure, function and application of the hammerhead ribozyme. Eur. J. Biochem. 245:1997;1-16.
13. Burke J.M., Berzal-Herranz A. In vitro selection and evolution of RNA - applications for catalytic RNA, molecular recognition, and drug discovery. FASEB J. 7:1993;106-112.
14. Campbell T.B., McDonald C.K., Hagen M. The effect of structure in a long target RNA on ribozyme cleavage efficiency. Nucleic Acids Res. 25:1997;4985-4993.
15. Castanotto D., Bertrand E., Rossi J. Exogenous cellular delivery of ribozymes and ribozyme encoding DNAs. Turner P.C. Ribozyme Protocols. 1997;429-439 Humana Press, Totowa, NJ.
16. Cech T.R. Ribozymes and their medical implications. JAMA. 260:1988;3030-3034.
17. Cech T.R., Bass B.L. Biological catalysis by RNA. Annu. Rev. Biochem. 55:1986;599-629.
18. Cech T.R., Damberger S.H., Gutell R.R. Representation of the secondary and tertiary structure of group I introns. Struct. Biol. 1:1994;273-280.
19. Cech T.R., Zaug A.J., Grabowski P.J. In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvment of a guanosine nucleotide in the excision of the intervening sequence. Cell. 27:1981;487-496.
20. Czubayko F., Schulte A.M., Berchem G.J., Wellstein A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl. Acad. Sci. USA. 93:1996;14753-14758.
21. Daiger, S. P., Sullivan, L. S. and Rossiter, B. J. F. (1999) Retnet. http://www.sph.uth.tmc.edu/Retnet/.
22. Desjardin L.E., Hauswirth W.W. Developmentally important elements within the bovine opsin upstream region. Inv. Ophth. Vis. Sci. 37:1996;154-165.
23. DeYoung M.B., Siwkowski A., Hampel A. Determination of catalytic parameters of hairpin ribozymes. Turner P.C. Ribozyme Protocols. 1997;209-220 Humana Press, Totowa, NJ.
24. Di Polo A., Farber D.B. Rod photoreceptor-specific gene expression in human retinoblastoma cells. Proc. Natl. Acad. Sci. USA. 92:1995;4016-4020.
25. Drenser K.A., Timmers A.M., Hauswirth W.W., Lewin A.S. Ribozyme-targeted destruction of RNAs associated with ADRP. Inv. Ophth. Vis. Sci. 39:1998;681-689.
26. Dryja T.P., Li T. Molecular genetics of retinitis pigmentosa. Hum. Mol. Genet. 4:1995;1739-1743.
27. Earnshaw D.J., Gait M.J. Progress toward the structure and therapeutic use of the hairpin ribozyme. Antisense & Nucleic Acid Drug Development. 7:1997;403-411.
28. Faktorovich E.G., Steinberg R.H., Yasumura D., Matthes M.T., LaVail M.M. Photoreceptor degeneration in inherited dystrophy delayed by the basic fibroblast growth factor. Nature. 347:1990;83-86.
29. Fallaux F.J., Bout A., van den Wollenberg D.J., Hehir K.M., Keegan J., Auger C., Cramer S.J., van Ormondt H., van der Eb A.J., Valerio D., Hoeben R.C. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9:1998;1909-1917.
30. Fedor M.J., Uhlenbeck O.C. Kinetics of intermolecular cleavage by hammerhead ribozymes. Biochemistry. 31:1992;12042-12054.
31. Flannery J.G., Zolotukhin S., Vaquero M.I., LaVail M.M., Muzyczka N., Hauswirth W.W. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA. 94:1997;6916-6921.
32. Flotte T.R., Afione S.A., Conrad C., McGrath S.A., Solow R., Oka H., Zeitlin P.L., Guggino W.B., Carter B.J. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA. 90:1993;10613-10617.
33. Flotte T.R., Afione S.A., Solow R., Drumm M.L., Markakis D., Guggino W.B., Zeitlin P.L., Carter B.J. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268:1993;3781-3790.
34. Flotte T.R., Carter B.J. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:1995;357-362.
35. Flotte T.R., Carter B.J., Conrad C.K., Guggino W.B., Reynolds T.C., Rosenstein B.J., Taylor G., Walden S., Wetzel R. Clinical protocol: a phase I trial of an adeno associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7:1996;1145-1159.
36. Gervaix A., Schwarz L., Law P., Ho A.D., Looney D., Lane T., Wong-Staal F. Gene therapy targeting peripheral blood CD34(+) hematopoietic stem cells of HIV-infected individuals. Hum. Gene Ther. 8:1997;2229-2238.
37. Green R., Noller H.F. Reconstitution of functional 50 S ribosomes from in vitro transcripts of Bacillus stearothermophilus 23 S rRNA. Biochem. 38:1999;1772-1779.
38. Guerrier-Takada C., Gardiner K., Marsh T., Pace N., Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell. 35:1983;849-857.
39. Guerrier-Takada C., Salavati R., Altman S. Phenotypic conversion of drug-resistant bacteria to drug sensitivity. PNAS. 94:1997;8468-8472.
40. Hampel A., Tritz R., Hicks M., Cruz P. "Hairpin" catalytic RNA model: evidence for helices and sequence requirement for substrate RNA. Nucleic Acids Res. 18:1990;299-304.
41. Hauswirth, W. W., Lewin, A. S., Zolotukhin, S. and Muzyczka, N. (2000a) Production and purification of recombinant AAV vectors. In Vertebrate Phototransduction and the Visual Cycle in Methods of Enzymology 316, 743-761 (ed. K. Palczewski). Academic Press, New York.
42. Hauswirth W.W., Shaw L.C., Whalen P., Fritz J., White D., Lewin A. Inhibition of gene expression by ribozymes. Rackozy E. Ocular Molecular Biology Protocols. 2000;The Humana Press, New York.
43. Hertel K.J., Herschlag D., Uhlenbeck O.C. A kinetic and thermodynamic framework for the hammerhead ribozyme reaction. Biochemistry. 33:1994;3374-3385.
44. Hertel K.J., Herschlag D., Uhlenbeck O.C. Specificity of hammerhead ribozyme cleavage. EMBO J. 15:1996;3751-3757.
45. Herzog R.W., Hagstrom J.N., Kung S.H., Tai S.J., Wilson J.M., Fisher K.J., High K.A. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA. 94:1997;5804-5809.
46. Hodgson, C. P., Chakraborty, A. K. and Bohman, B. M. (1993) Retroviral vectors for gene therapy and transgenics. Curr. Opin. Ther. Pat., 223-235.
47. Hormes R., Homann M., Oelze I., Marschall P., Tabler M., Eckstein F., Sczakiel G. The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells. Nucleic. Acids. Res. 25:1997;769-775.
48. Huang P.C., Gaitan A.E., Hao Y., Petters R.M., Wong F. Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc. Natl. Acad. Sci. USA. 90:1993;8484-8488.
49. Humphries P., Kenna P., Farrar G.J. On the molecular basis of retinitis pigmentosa. Science. 256:1992;804-808.
50. Jones J.T., Sullenger B.A. Evaluating and enhancing ribozyme reaction efficiency in mammalian cells. Nature Biotechnol. 15:1997;902-905.
51. Joseph S., Berzal-Herranz A., Chowrira B.M., Butcher S.E., Burke J.M. Substrate selection rules for the hairpin ribozyme determined by in vitro selection, mutation, and analysis of mismatched substrates. Gene. Develop. 7:1993;130-138.
52. Joyce G.F. The rise and fall of the RNA world. New Biol. 3:1991;399-407.
53. Kashani Sabet M., Funato T., Florenes V.A., Fodstad O., Scanlon K.J. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer. Res. 54:1994;900-902.
54. Kearns W.G., Afione S.A., Fulmer S.B., Pang M.C., Erikson D., Egan M., Landrum M.J., Flotte T.R., Cutting G.R. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:1996;748-755.
55. Kessler P.D., Podsakoff G.M., Chen X., McQuiston S.A., Colosi P.C., Matelis L.A., Kurtzman G.J., Byrne B.J. Gene delivery to skeletal muscle results in sustained expression and systematic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA. 93:1996;14082-14087.
56. Khaitovich P., Tenson T., Kloss P., Mankin A.S. Reconstitution of functionally active Thermus aquaticus large ribosomal subunits with in vitro-transcribed rRNA. Biochem. 38:1999;1780-1788.
57. Klein R.L., Meyer E.M., Peel A.L., Zolotukhin S., Meyers C., Muzyczka N., King M.A. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp. Neurol. 150:1998;183-194.
58. Köhler U., Ayre B.G., Goodman H.M., Haseloff J. Trans-splicing ribozymes for targeted gene delivery. J. Mol. Biol. 285:1999;1935-1950.
59. Koizumi M., Kamiya H., Ohtsuka E. Inhibition of c-Ha-ras gene expression by hammerhead ribozymes containing a stable C(UUCG)G hairpin loop. Biol. Pharm. Bull. 16:1993;879-883.
60. Kumar-Singh R., Farber D.B. Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration. Hum. Mol. Genet. 7:1998;1893-1900.
61. Lan N., Howrey R.P., Lee S.W., Smith C.A., Sullenger B.A. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science. 280:1998;1593-1596.
62. LaVail M.M., Battelle B.A. Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp. Eye Res. 21:1975;167-192.
63. Lewin A.S., Drenser K.A., Hauswirth W.W., Nishikawa S., Yasumura D., Flannery J.G., LaVail M.M. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med. 4:1998;967-971.
64. Li T., Adamian M., Roof D.J., Berson E.L., Dryja T., Roessler B.J., Davidson B.J. In vivo transfer of a reporter gene into the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci. 35:1994;2543-2549.
65. Liu F., Altman S. Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli. Genes Dev. 9:1995;471-480.
66. Long M.B., Sullenger B.A. Evaluating group I intron catalytic efficiency in mammalian cells. Mol. Cell Biol. 19:1999;6479-6487.
67. Macpherson J.L., Ely J.A., Sun L.Q., Symonds G.P. Ribozymes in gene therapy of HIV-1. Front Biosci. 4:1999;D497-D505.
68. Michon J.J., Li Z.L., Shioura N., Anderson R.J., Tso M.O. A comparative study of methods of photoreceptor morphometry. Invest. Ophthalmol. Vis. Sci. 32:1991;280-284.
69. Miller A.D. Retroviral vectors. Muzyczka N. Current topics in Microbiology and Immunology. Vol. 158:1992;1-24 Springer Verlag, Berlin.
70. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:1989;980-990.
71. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:1992;4239-4242.
72. Milligan J.F., Groebe D.R., Witherell G.W., Uhlenbeck O.C. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15:1987;8783-8798.
73. Millington-Ward S., O'Neill B., Tuohy G., Al-Jandal N., Kiang A.S., Kenna P.F., Palfi A., Hayden P., Mansergh F., Kennan A., Humphries P., Farrar G.J. Strategems in vitro for gene therapies directed to dominant mutations. Hum. Mol. Genet. 6:1997;1415-1426.
74. Mitani K., Graham F.L., Caskey C.T., Kochanek S. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA. 92:1995;3854-3858.
75. Miyoshi H., Takahashi M., Gage F.H., Verma I.M. Stable and efficient gene transfer into retina using an HIV-based lentiviral vector. PNAS. 94:1997;10319-10323.
76. Mohand-Said S., Hicks D., Simonutti M., Tran-Minh D., Deudon-Combe A., Dreyfus H., Silverman M.S., Ogilvie J.M., Tenkova T., Sahel J. Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse. Ophthalmic Res. 29:1997;290-297.
77. Mulligan R.C. The basic science of gene therapy. Science. 260:1993;926-932.
78. Muzyczka N. Use of AAV as a general transduction vector for mammalian cells. Muzyczka N. Current Topics in Microbiology and Immunology. Vol. 158:1992;97-129 Springer Verlag, Berlin.
79. Ozaki I., Zern M.A., Liu S., Wei D.L., Pomerantz R.J., Duan L. Ribozyme-mediated specific gene replacement of the alpha1-antitrypsin gene in human hepatoma cells. J. Hepatol. 31:1999;53-60.
80. Peel A.L., Zolotukhin S., Schrimsher G.W., Muzyczka N., Reier P.J. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 4:1997;16-24.
81. Peral B., San Millan J.L., Ong A.C., Gamble V., Ward C.J., Strong C., Harris P.C. Screening the 3′ region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations. Am. J. Hum. Genet. 58:1996;86-96.
82. Plehn-Dujowich D., Altman S. Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P. Proc. Natl. Acad. Sci. USA. 95:1998;7327-7332.
83. Ponnazhagan S., Erikson D., Kearns W.G., Zhou S.Z., Nahreini P., Wang X.S., Srivastava A. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8:1997;275-284.
84. Puttaraju M., Jamison S.F., Mansfield S.G., Garcia-Blanco M.A., Mitchell L.G. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy [see comments] [published erratum appears in Nat. Biotechnol. 1999 17(6): 602]. Nat. Biotechnol. 17:1999;246-252.
85. Reichel M.B., Ali R.R., Thrasher A.J., Hunt D.M., Bhattacharya S.S., Baker D. Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther. 5:1998;1038-1046.
86. Rolling F., Nong Z., Pisvin S., Collen D. Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther. 4:1997;757-761.
87. Russell D.W., Hirata R.K. Human gene targeting by viral vectors. Nat. Genet. 18:1998;325-330.
88. Santoro S.W., Joyce G.F. Mechanism and utility of an RNA-cleaving DNA enzyme. Biochem. 37:1998;13330-13342.
89. Sargueil B., Pecchia D.B., Burke J.M. An improved version of the hairpin ribozyme functions as a ribonucleoprotein complex. Biochem. 34:1995;7739-7748.
90. Sarver N., Cantin E.M., Chang P.S., Zaia J.A., Lande P.A., Stephens D.A., Rossi J.J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science. 247:1990;1222-1225.
91. Seelig B., Jaschke A. A small catalytic RNA motif with Diels-Alderase activity. Chem. Biol. 6:1999;167-176.
92. Shaw, L. C., Whalen, P., Drenser, K. A., Hauswirth, W. W. and Lewin, A. S. (2000) Ribozymes in the treatment of retinal disease. In Vertebrate Phototransduction and the Visual Cycle In Methods of Enzymology 316, 761-776 (ed. K. Palczewski). Academic Press, New York.
93. Shimayama T., Nishikawa S., Taira K. Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. Biochem. 34:1995;3649-3654.
94. Siwkowski A., Shippy R., Hampel A. Analysis of hairpin ribozyme base mutations in loops 2 and 4 and their effects on cis-cleavage in vitro. Biochem. 36:1997;3930-3940.
95. Snyder R.O., Miao C.H., Patijn G.A., Spratt S.K., Danos O., Nagy D., Gown A.M., Winther B., Meuse L., Cohen L.K., Thompson A.R., Kay M.A. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16:1997;270-276.
96. Song S., Morgan M., Ellis T., Poirier A., Chesnut K., Wang J., Brantly M., Muzyczka N., Byrne B.J., Atkinson M., Flotte T.R. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA. 95:1998;14384-14388.
97. Stage-Zimmermann T.K., Uhlenbeck O.C. Hammerhead ribozyme kinetics. RNA. 4:1998;875-889.
98. Studier F.W., Rosenberg A.H., Dunn J.J., Dubendorff J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;60-89.
99. Sullenger B.A., Cech T.R. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing. Nature. 371:1994;619-622.
100. Sullivan J.M., Pietras K.E. Design and testing of hammerhead ribozymes to cleave full length opsin mRNA. Investigations Ophthalmol. Vision Sci. 39:(4):1998;S722.
101. Takahashi M., Miyoshi H., Verma I.M., Gage F.H. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J. Virol. 73:1999;7812-7816.
102. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 249:1990;505-510.
103. Tuschl T., Sharp P.A., Bartel D.P. Selection in vitro of novel ribozymes from a partially randomized U2 and U6 snRNA library. EMBO J. 17:1998;2637-2650.
104. Vaish N.K., Heaton P.A., Fedorova O., Eckstein F. In vitro selection of a purine nucleotide-specific hammerhead-like ribozyme. Proc. Natl. Acad. Sci. USA. 95:1998;2158-2162.
105. Walstrum S.A., Uhlenbeck O.C. The self-splicing RNA of Tetrahymena is trapped in a less active conformation by gel purification. Biochem. 29:1990;10573-10576.
106. Wen R., Song Y., Cheng T., Matthes M.T., Yasumura D., LaVail M.M., Steinberg R.H. Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J. Neurosci. 15:1995;7377-7385.
107. Wong-Staal F., Poeschla E.M., Looney D.J. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum. Gene Ther. 9:1998;2407-2425.
108. Xiao X., Li J., McCown T.J., Samulski R.J. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp. Neurol. 144:1997;113-124.
109. Xiao X., Li J., Samulski R.J. Efficient long-term transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108.
110. Yan W., Lewin A., Hauswirth W. Selective degradation of nonsense beta-phosphodiesterase mRNA in the heterozygous rd mouse. Invest. Ophthalmol. Vis. Sci. 39:1998;2529-2536.
111. Yu M., Poeschla E., Yamada O., Degrandis P., Leavitt M.C., Heusch M., Yees J.K., Wong Staal F., Hampel A. In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1. Virology. 206:1995;381-386.
112. Yu Q., Pecchia D.B., Kingsley S.L., Heckman J.E., Burke J.M. Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. The most effective ribozymes are not predicted by substrate selection rules [In Process Citation]. J. Biol. Chem. 273:1998;23524-23533.
113. Zarrinkar P.P., Sullenger B.A. Optimizing the substrate specificity of a group I intron ribozyme. Biochem. 38:1999;3426-3432.
114. Zern M.A., Ozaki I., Duan L., Pomerantz R., Liu S.L., Strayer D.S. A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Gene Ther. 6:1999;114-120.
115. Zhang B., Cech T.R. Peptide bond formation by in vitro selected ribozymes. Nature. 390:1997;96-100.
116. Zhang B., Cech T.R. Peptidyl-transferase ribozymes: trans reactions, structural characterization and ribosomal RNA-like features. Chem. Biol. 5:1998;539-553.
117. Zolotukhin S., Byrne B., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R., Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:1999;973-985.
118. Zolotukhin S., Potter M., Hauswirth W.W., Guy J., Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:1996;4646-4654.